The American Thoracic Society recently published updated guidelines for IPF.  These new guidelines reflect the recent advances in treatment.  We provide the link for those interested in the unabridged document.  Below I summarize the recommendations. New and Revised Recommendations Against Use 1.     Anticoagulation:  strong recommendation against use for treatment of … [Read more...]

Patients with Idiopathic Pulmonary Fibrosis (IPF) often enjoy prolonged periods of stability where their disease does not progress.  Other patients may have very gradual worsening of symptoms.  On this background, IPF patients at times may experience more abrupt decline.  Many patients first notice increased cough followed by increased shortness of breath.  This pattern should … [Read more...]